Jackson Creek Investment Advisors LLC Amphastar Pharmaceuticals, Inc. Transaction History

Jackson Creek Investment Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	SELL	$44.49 - $62.93 $88 - $125	-2 Reduced 0.01%	16,618 $1.03 Million
Q3 2023 Nov 03, 2023	SELL	$45.51 - $65.0 $461,380 - $658,970	-10,138 Reduced 37.89%	16,620 $764,000
Q2 2023 Aug 02, 2023	BUY	$35.77 - $58.38 $31,513 - $51,432	881 Added 3.4%	26,758 $1.54 Million
Q1 2023 May 02, 2023	BUY	$27.99 - $37.92 $724,297 - $981,255	25,877 New	25,877 $970,000
Q3 2022 Nov 09, 2022	SELL	$27.56 - $37.75 $34,725 - $47,565	-1,260 Reduced 4.37%	27,577 $775,000
Q2 2022 Aug 04, 2022	SELL	$29.79 - $42.29 $624,904 - $887,117	-20,977 Reduced 42.11%	28,837 $1.08 Million
Q1 2022 May 03, 2022	BUY	$22.96 - $36.45 $1.14 Million - $1.82 Million	49,814 New	49,814 $1.79 Million
Q4 2020 Feb 03, 2021	SELL	$17.76 - $21.24 $649,838 - $777,171	-36,590 Closed	0 $0
Q3 2020 Nov 09, 2020	BUY	$17.99 - $22.22 $658,254 - $813,029	36,590 New	36,590 $686,000

286

34.9M

74.3K

22.3K

Ticker AMPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,015,200
Market Cap $1.92B
Description
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.